Screening of SPATA7 in Patients with Leber Congenital Amaurosis and Severe Childhood-Onset Retinal Dystrophy Reveals Disease-Causing Mutations

Total Page:16

File Type:pdf, Size:1020Kb

Screening of SPATA7 in Patients with Leber Congenital Amaurosis and Severe Childhood-Onset Retinal Dystrophy Reveals Disease-Causing Mutations Genetics Screening of SPATA7 in Patients with Leber Congenital Amaurosis and Severe Childhood-Onset Retinal Dystrophy Reveals Disease-Causing Mutations Donna S. Mackay,1 Louise A. Ocaka,1 Arundhati Dev Borman,1,2 Panagiotis I. Sergouniotis,1,2 Robert H. Henderson,2 Phillip Moradi,2 Anthony G. Robson,1,2 Dorothy A. Thompson,3,4 Andrew R. Webster,1,2 and Anthony T. Moore1,2 PURPOSE. To investigate the prevalence of sequence variants in loss, but may have some preservation of the photoreceptor the gene SPATA7 in patients with Leber congenital amaurosis structure in the central retina. (Invest Ophthalmol Vis Sci. (LCA) and autosomal recessive, severe, early-onset retinal dys- 2011;52:3032–3038) DOI:10.1167/iovs.10-7025 trophy (EORD) and to delineate the ocular phenotype associ- ated with SPATA7 mutations. eber congenital amaurosis (LCA), first described by The- METHODS. Patients underwent standard ophthalmic evaluation odor Leber in 1869,1 is a generalized retinal dystrophy after providing informed consent. One hundred forty-one DNA L which presents at birth, or soon after, with severe visual samples from patients with LCA and EORD had been analyzed impairment and nystagmus. LCA accounts for 3% to 5% of for mutations by using a microarray, with negative results. One childhood blindness in the developed world and has an inci- additional patient underwent SPATA7 screening due to a re- dence of 2 to 3 per 100,000 live births.2 The clinical features gion of autozygosity surrounding this gene. A further patient include severe visual loss, sluggish pupillary responses, and was screened who had a compatible ocular phenotype. The roving eye movements. The retinal appearance may be normal entire SPATA7 coding sequence was assayed, including the at diagnosis, or there may be a variety of abnormalities, includ- intron–exon junctions, by using a combination of direct DNA ing macular atrophy, peripheral white dots at the level of the sequencing and high-resolution melting screening. retinal pigment epithelium (RPE), RPE atrophy, and/or retinal RESULTS. Screening of SPATA7 identified several known and pigmentation. The full-field electroretinogram (ERG) is usually novel single-nucleotide polymorphisms (SNPs). Affected indi- unrecordable.3,4 viduals from five unrelated families were identified to have Most forms of LCA are inherited as an autosomal recessive coding changes. Clinical features demonstrated a severe infan- (AR) trait, although rare dominant forms have been reported. tile onset retinal dystrophy, similar to Leber congenital amau- To date, 14 causative genes (GUCY2D,5 AIPL1,6 RPE65,7 rosis. The retina had widespread retinal pigment epithelial RPGRIP1,8 CRX,9 TULP1,10 CRB1,11 RDH12,12 CEP290,13 atrophy, with minimal pigment migration into the neurosen- LCA5,14 SPATA7,15 LRAT,16 MERTK17 and IQCB118) with one sory retina. Fundus autofluorescence imaging showed a para- further locus, LCA9,19 have been reported to be associated foveal annulus of increased autofluorescence. High-definition with autosomal recessive LCA. Mutations in some of these optical coherence tomography showed preservation of the genes are also associated with severe rod–cone dystrophies inner segment/outer segment junction at the fovea. presenting later in childhood. 20 CONCLUSIONS. Mutations in SPATA7 are a rare cause of child- The LCA3 locus was identified in 1998 by linkage analysis hood retinal dystrophy accounting for 1.7% of disease in this in a large consanguineous family from Saudi Arabia. A second cohort. Affected patients present in infancy with severe visual family, also from Saudi Arabia, was found to map to the same region of chromosome 14. RDH12, a positional candidate, was excluded as the disease gene, suggesting that this locus repre- sented a novel gene for LCA.21 In 2009, SPATA7 was identified From the 1Department of Genetics, Institute of Ophthalmology, as the causative gene at this locus after further fine mapping of London, United Kingdom; 2Moorfields Eye Hospital, London, United one of the linked families.15 Four novel mutations were found 3 Kingdom; the Clinical and Academic Department of Ophthalmology, in five families with LCA or juvenile onset retinitis pigmentosa Great Ormond Street Hospital for Children, London, United Kingdom; 4 (RP). Recently, a further four families with six mutations (four and the Institute of Child Health, University College London, United 22 Kingdom. of which were novel) have been identified. SPATA7 (spermatogenesis associated protein 7) was first Supported by Fight for Sight Grant 1624 (UK), the National Insti- 23 tute for Health Research UK (Moorfields Eye Hospital Biomedical cloned in 2003 from the rat testis and called RSD-3/HSD-3.1. Research Centre, London, UK), Alexander S. Onassis Public Benefit The corresponding human cDNA was also found to be ex- Foundation (Greece), the Foundation Fighting Blindness (USA), and pressed in the human testis. The human gene (MIM 609868; the Ulverscroft foundation. Mendelian Inheritance in Man; National Center for Biotechnol- Submitted for publication December 9, 2010; revised January 11, ogy Information, Bethesda, MD) consisted of 12 exons that 2011; accepted January 11, 2011 spanned approximately 52.8 kb and mapped to chromosome Disclosure: D.S. Mackay, None; L.A. Ocaka, None; A.D. Borman, 14, region q31.3. The gene encodes a protein of 599 amino None; P.I. Sergouniotis, None; R.H. Henderson, None; P. Moradi, None; acids. It is conserved from sea urchin to human, but is absent A.G. Robson, None; D.A. Thompson, None; A.R. Webster, None; A.T. 15 Moore, None in lower eukaryotes. Analysis of the protein using the PSIPred Corresponding author: Donna S. Mackay, Department of Genetics, program (provided in the public domain by Bioinformatics Institute of Ophthalmology, 11-43 Bath Street, London, UK EC1V 9EL; Group, Department of Computer Science, University College [email protected]. London, at http://bioinf.cs.ucl.ac.uk/introduction) showed Investigative Ophthalmology & Visual Science, May 2011, Vol. 52, No. 6 3032 Copyright 2011 The Association for Research in Vision and Ophthalmology, Inc. Downloaded from jov.arvojournals.org on 10/02/2021 IOVS, May 2011, Vol. 52, No. 6 SPATA7 Mutations 3033 one transmembrane domain but no known functional domains. coherence tomography (SD-OCT; Spectralis Spectral domain OCT scan- Expression in the mouse retina was found in multiple retinal ner; Heidelberg Engineering, Germany) and retinal autofluorescence layers, including the ganglion cell and inner nuclear layers and (AF) imaging with a confocal scanning laser ophthalmoscope (Zeiss in the inner segments of photoreceptors. Expression levels at Prototype; Carl Zeiss Meditec, GmbH, Oberkochen, Germany). Pattern different time points suggested that Spata7 is important for and full-field electroretinography (PERG and ERG) were performed in normal retinal function rather than development.15 A recent consideration of the recommendations of the International Society for report on the Spata7-knockout mouse suggested that the pro- Clinical Electrophysiology of Vision (ISCEV) or using a modified pedi- tein is involved in protein transport (Abulimiti Sr A, et al. IOVS atric ERG protocol with skin electrodes, as previously described.25–28 2010;51:ARVO E-Abstract 723). Blood samples were collected in EDTA tubes, and DNA was ex- Two isoforms of SPATA7 are known to be expressed.24 tracted with a blood-extraction kit (Puregene; Invitrogen, Paisley, UK), Expression analysis of these two isoforms in 22 adult and fetal according to the manufacturer’s instructions. human tissues showed high levels in the retina, cerebellum, From a total of 292 subjects recruited into this study, DNA samples whole brain, and testis. Isoform 1 was more highly expressed from 141 subjects with no known mutations in LCA genes were chosen than was isoform 2 (missing exon 3) in neuronal tissues, for SPATA7 mutation screening. whereas isoform 2 was highly expressed in the testis.22 To evaluate the role of SPATA7 in childhood-onset retinal Microarray SNP6 Autozygosity Mapping dystrophies in the British population, we screened 141 patients Subject 2 from family 3 was chosen for analysis with a gene microarray with LCA or early childhood onset severe retinal dystrophy for (SNP6.0 array; Affymetrix, Santa Clara, CA), according to the manufac- all the coding exons, using a combination of melting curve turer’s instructions. Genotypes for single-nucleotide polymorphisms analysis and Sanger sequencing. We also investigated the phe- (SNPs) were called by gene analysis software (GeneChip DNA Analysis notype associated with SPATA7 mutations. Software; GDAS ver. 3.0; Affymetrix). Regions of homozygosity were also identified on computer (AutoSNPa; provided in the public domain MATERIALS AND METHODS by the Leeds Institute of Molecular Medicine, University of Leeds, UK, at http://dna.leeds.ac.uk/autospna/).29 Clinical Investigations All patients in this study had a clinical diagnosis of LCA or severe AR Mutation Screening retinal dystrophy with symptom onset before 6 years of age. All Primers used to amplify the coding exons and the intron-exon bound- provided informed consent as part of a research project approved by aries of SPATA7 were designed by hand. Primer sequences are shown the local research ethics committee, and all investigations were con- in Table 1. Exons 2 to 5 were initially screened with the high-resolution ducted in accordance with the principles of the Declaration of Hel- melting curve technique (LightScanner; Idaho Technology, Salt Lake sinki. A clinical evaluation, including monocular best corrected visual City, UT), with abnormal melting curves identified and then se- acuity (BCVA), perimetry, and slit lamp biomicroscopy was performed quenced. All other exons were directly sequenced. All standard poly- on all patients who could cooperate with testing. Patients underwent merase chain reactions (PCRs) were performed in a total volume of 30 retinal imaging (TRC 501A retinal camera; Topcon Corp., Tokyo, Ja- ␮L containing 200 ␮M dNTPs (VH Bio, Gateshead, UK), 20 ␮M of each ϫ pan) and, where possible, high-resolution spectral domain optical primer, 1 reaction buffer including 1.5 mM MgCl2 (VH Bio), with 1 TABLE 1.
Recommended publications
  • Mutation of SPATA7 in a Family with Autosomal Recessive Early-Onset Retinitis Pigmentosa
    JournalofMolecularandGeneticMedicine,2012,Vol6,301-303 RESEARCH LETTER Mutation of SPATA7 in a family with autosomal recessive early-onset retinitis pigmentosa Chitra Kannabiran†*, Lakshmi Palavalli† and Subhadra Jalali‡ † Kallam Anji Reddy Molecular Genetics Laboratory, Prof Brien Holden Eye Research Centre, Hyderabad Eye Research Foundation, L V Prasad Eye Institute, Kallam Anji Reddy Campus, Banjara Hills, Hyderabad 500034, India, ‡ Srimati Kanuri Santhamma Centre for Vitreoretinal Diseases, L V Prasad Eye Institute, Kallam Anji Reddy Campus, Banjara Hills, Hyderabad 500034, India. *Correspondence to: Chitra Kannabiran, E-mail: [email protected]; [email protected] Received: 09 November 2012; Revised: 11 December 2012; Accepted: 11 December 2012; Published: 12 December 2012 © Copyright The Author(s): Published by Library Publishing Media. This is an open access article, published under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5). This license permits non-commercial use, distribution and reproduction of the article, provided the original work is appro- priately acknowledged with correct citation details. Retinitis pigmentosa (RP) is a form of hereditary retinal The genes that were screened for sequence changes in the degeneration with a high degree of clinical and genetic het- present study included RDH12 and SPATA7. Primers comple- erogeneity. It involves progressive and irreversible degen- mentary to flanking intronic regions of each exon were used eration of retinal photoreceptors, manifests as progressive for PCR amplification of the coding regions of both genes loss of vision with characteristic changes in retinal appear- using appropriate conditions. The PCR-amplified products ance and may eventually lead to complete blindness.
    [Show full text]
  • A Yeast Bifc-Seq Method for Genome-Wide Interactome Mapping
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.16.154146; this version posted June 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 A yeast BiFC-seq method for genome-wide interactome mapping 2 3 Limin Shang1,a, Yuehui Zhang1,b, Yuchen Liu1,c, Chaozhi Jin1,d, Yanzhi Yuan1,e, 4 Chunyan Tian1,f, Ming Ni2,g, Xiaochen Bo2,h, Li Zhang3,i, Dong Li1,j, Fuchu He1,*,k & 5 Jian Wang1,*,l 6 1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National 7 Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 102206, 8 China; 2Department of Biotechnology, Beijing Institute of Radiation Medicine, 9 Beijing 100850, China; 3Department of Rehabilitation Medicine, Nan Lou; 10 Department of Key Laboratory of Wound Repair and Regeneration of PLA, College 11 of Life Sciences, Chinese PLA General Hospital, Beijing 100853, China; 12 Correspondence should be addressed to F.H. ([email protected]) and J.W. 13 ([email protected]). 14 * Corresponding authors. 15 E-mail:[email protected] (Fuchu He),[email protected] (Jian Wang) 16 a ORCID: 0000-0002-6371-1956. 17 b ORCID: 0000-0001-5257-1671 18 c ORCID: 0000-0003-4691-4951 19 d ORCID: 0000-0002-1477-0255 20 e ORCID: 0000-0002-6576-8112 21 f ORCID: 0000-0003-1589-293X 22 g ORCID: 0000-0001-9465-2787 23 h ORCID: 0000-0003-3490-5812 24 i ORCID: 0000-0002-3477-8860 25 j ORCID: 0000-0002-8680-0468 26 k ORCID: 0000-0002-8571-2351 27 l ORCID: 0000-0002-8116-7691 28 Total word counts:4398 (from “Introduction” to “Conclusions”) 29 Total Keywords: 5 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.16.154146; this version posted June 17, 2020.
    [Show full text]
  • US 2009/0270267 A1 Akiyama Et Al
    US 20090270267A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0270267 A1 Akiyama et al. (43) Pub. Date: Oct. 29, 2009 (54) COMPOSITION AND METHOD FOR (86). PCT No.: PCT/UP2006/309.177 DAGNOSINGESOPHAGEAL CANCER AND METASTASS OF ESOPHAGEAL CANCER S371 (c)(1), (2), (4) Date: Jan. 8, 2008 (75) Inventors: Hideo Akiyama, Kanagawa (JP); O O Satoko Kozono, Kanagawa (JP); (30) Foreign Application Priority Data 6A yet S. (JP): (JP): May 2, 2005 (JP) ................................. 2005-134530 Sam Nomura, Kanagaway): Sep. 13, 2005 (JP) ................................. 2005-265645 Hitoshi Nobumasa, Shiga (JP); Sep. 13, 2005 (JP) 2005-265678 Yoshinori Tanaka, Kanagawa (JP); O. l. 4UUC ) . Shiori Tomoda, Tokyo (JP); Publication Classification Yutaka Shimada, Kyoto (JP); Gozoh Tsujimoto, Kyoto (JP) (51) Int. Cl. C40B 30/04 (2006.01) Correspondence Address: CI2O I/68 (2006.01) BRCH STEWARTKOLASCH & BRCH GOIN 33/53 (2006.01) PO BOX 747 C40B 40/08 (2006.01) FALLS CHURCH, VA 22040-0747 (US) (52) U.S. Cl. ..................... 506/9; 435/6: 435/7.1:506/17 (73) Assignees: TORAY INDUSTRIES, INC., (57) ABSTRACT Tokyo (JP); Kyoto University, This invention relates to a composition, kit, or DNA chip Kyoto-shi (JP) comprising polynucleotides and antibodies as probes for detecting, determining, or predicting the presence or metasta (21) Appl. No.: 11/919,679 sis of esophageal cancer, and to a method for detecting, deter mining, or predicting the presence or metastasis of esoph (22) PCT Filed: May 2, 2006 ageal cancer using the same. Patent Application Publication Oct. 29, 2009 Sheet 1 of 5 US 2009/0270267 A1 Fig.
    [Show full text]
  • Content Based Search in Gene Expression Databases and a Meta-Analysis of Host Responses to Infection
    Content Based Search in Gene Expression Databases and a Meta-analysis of Host Responses to Infection A Thesis Submitted to the Faculty of Drexel University by Francis X. Bell in partial fulfillment of the requirements for the degree of Doctor of Philosophy November 2015 c Copyright 2015 Francis X. Bell. All Rights Reserved. ii Acknowledgments I would like to acknowledge and thank my advisor, Dr. Ahmet Sacan. Without his advice, support, and patience I would not have been able to accomplish all that I have. I would also like to thank my committee members and the Biomed Faculty that have guided me. I would like to give a special thanks for the members of the bioinformatics lab, in particular the members of the Sacan lab: Rehman Qureshi, Daisy Heng Yang, April Chunyu Zhao, and Yiqian Zhou. Thank you for creating a pleasant and friendly environment in the lab. I give the members of my family my sincerest gratitude for all that they have done for me. I cannot begin to repay my parents for their sacrifices. I am eternally grateful for everything they have done. The support of my sisters and their encouragement gave me the strength to persevere to the end. iii Table of Contents LIST OF TABLES.......................................................................... vii LIST OF FIGURES ........................................................................ xiv ABSTRACT ................................................................................ xvii 1. A BRIEF INTRODUCTION TO GENE EXPRESSION............................. 1 1.1 Central Dogma of Molecular Biology........................................... 1 1.1.1 Basic Transfers .......................................................... 1 1.1.2 Uncommon Transfers ................................................... 3 1.2 Gene Expression ................................................................. 4 1.2.1 Estimating Gene Expression ............................................ 4 1.2.2 DNA Microarrays ......................................................
    [Show full text]
  • Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss
    cells Review Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss 1, 1, 1 1,2,3 1 Gayle B. Collin y, Navdeep Gogna y, Bo Chang , Nattaya Damkham , Jai Pinkney , Lillian F. Hyde 1, Lisa Stone 1 , Jürgen K. Naggert 1 , Patsy M. Nishina 1,* and Mark P. Krebs 1,* 1 The Jackson Laboratory, Bar Harbor, Maine, ME 04609, USA; [email protected] (G.B.C.); [email protected] (N.G.); [email protected] (B.C.); [email protected] (N.D.); [email protected] (J.P.); [email protected] (L.F.H.); [email protected] (L.S.); [email protected] (J.K.N.) 2 Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand 3 Siriraj Center of Excellence for Stem Cell Research, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand * Correspondence: [email protected] (P.M.N.); [email protected] (M.P.K.); Tel.: +1-207-2886-383 (P.M.N.); +1-207-2886-000 (M.P.K.) These authors contributed equally to this work. y Received: 29 February 2020; Accepted: 7 April 2020; Published: 10 April 2020 Abstract: Inherited retinal degeneration (RD) leads to the impairment or loss of vision in millions of individuals worldwide, most frequently due to the loss of photoreceptor (PR) cells. Animal models, particularly the laboratory mouse, have been used to understand the pathogenic mechanisms that underlie PR cell loss and to explore therapies that may prevent, delay, or reverse RD. Here, we reviewed entries in the Mouse Genome Informatics and PubMed databases to compile a comprehensive list of monogenic mouse models in which PR cell loss is demonstrated.
    [Show full text]
  • Comprehensive Genotyping Reveals RPE65 As the Most Frequently Mutated Gene in Leber Congenital Amaurosis in Denmark
    European Journal of Human Genetics (2016) 24, 1071–1079 & 2016 Macmillan Publishers Limited All rights reserved 1018-4813/16 www.nature.com/ejhg ARTICLE Comprehensive genotyping reveals RPE65 as the most frequently mutated gene in Leber congenital amaurosis in Denmark Galuh DN Astuti1,2,3,10, Mette Bertelsen4,5,6,10, Markus N Preising7, Muhammad Ajmal8, Birgit Lorenz7, Sultana MH Faradz3, Raheel Qamar8,9, Rob WJ Collin1,2, Thomas Rosenberg4,6 and Frans PM Cremers*,1,2,8 Leber congenital amaurosis (LCA) represents the most severe form of inherited retinal dystrophies with an onset during the first year of life. Currently, 21 genes are known to be associated with LCA and recurrent mutations have been observed in AIPL1, CEP290, CRB1 and GUCY2D. In addition, sequence analysis of LRAT and RPE65 may be important in view of treatments that are emerging for patients carrying variants in these genes. Screening of the aforementioned variants and genes was performed in 64 Danish LCA probands. Upon the identification of heterozygous variants, Sanger sequencing was performed of the relevant genes to identify the second allele. In combination with prior arrayed primer extension analysis, this led to the identification of two variants in 42 of 86 cases (49%). Remarkably, biallelic RPE65 variants were identified in 16% of the cases, and one novel variant, p.(D110G), was found in seven RPE65 alleles. We also collected all previously published RPE65 variants, identified in 914 alleles of 539 patients with LCA or early-onset retinitis pigmentosa, and deposited them in the RPE65 Leiden Open Variation Database (LOVD). The in silico pathogenicity assessment of the missense and noncanonical splice site variants, as well as an analysis of their frequency in ~ 60 000 control individuals, rendered 864 of the alleles to affect function or probably affect function.
    [Show full text]
  • Genetics and Retinal Degeneration: Challenges in Optogenetic Therapy and Indentifying Pathogenic Variants
    University of Pennsylvania ScholarlyCommons Publicly Accessible Penn Dissertations 2017 Genetics And Retinal Degeneration: Challenges In Optogenetic Therapy And Indentifying Pathogenic Variants Laura Mary Bryant University of Pennsylvania, [email protected] Follow this and additional works at: https://repository.upenn.edu/edissertations Part of the Genetics Commons, and the Ophthalmology Commons Recommended Citation Bryant, Laura Mary, "Genetics And Retinal Degeneration: Challenges In Optogenetic Therapy And Indentifying Pathogenic Variants" (2017). Publicly Accessible Penn Dissertations. 2988. https://repository.upenn.edu/edissertations/2988 This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2988 For more information, please contact [email protected]. Genetics And Retinal Degeneration: Challenges In Optogenetic Therapy And Indentifying Pathogenic Variants Abstract Inherited retinal degenerative diseases are one of the leading causes of childhood blindness. While over 200 causative genes have been identified, many cases still have an unknown underlying genetic cause. With the advent of next generation sequencing (NGS), it should be possible to identify the genetic cause in almost every case, provided enough relatives are willing to participate. However, the massive amount of data generated by NGS can make identifying the pathogenic variant challenging. It is necessary to filter the data in order to create a manageable candidate list, but overly strict filtering or erroneous assumptions can result in filtering out the pathogenic ariant.v Identifying the genetic cause of retinal degeneration in each patient will allow us to better identify candidate genes for gene therapy and bring us a step closer to precision medicine. Here we developed an efficient screening system to find candidate mutations with minimal assumptions to avoid screening out pathogenic variants and better identify good candidates for novel gene discovery.
    [Show full text]
  • INTRODUCING a NOVEL METHOD for GENETIC ANALYSIS of AUTISM SPECTRUM DISORDER Sepideh Nouri
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2013 INTRODUCING A NOVEL METHOD FOR GENETIC ANALYSIS OF AUTISM SPECTRUM DISORDER sepideh nouri Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Bioinformatics Commons, Computational Biology Commons, and the Genomics Commons Recommended Citation nouri, sepideh, "INTRODUCING A NOVEL METHOD FOR GENETIC ANALYSIS OF AUTISM SPECTRUM DISORDER" (2013). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 417. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/417 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. INTRODUCING A NOVEL METHOD FOR GENETIC ANALYSIS OF AUTISM SPECTRUM DISORDER by Sepideh Nouri, M.S. APPROVED: Eric Boerwinkle, Ph.D., Supervisor Kim-Anh Do, Ph.D. Alanna Morrison, Ph.D. James Hixson, Ph.D. Paul Scheet, Ph.D. APPROVED: Dean, The University of Texas Graduate School of Biomedical Sciences at Houston INTRODUCING A NOVEL METHOD FOR GENETIC ANALYSIS OF AUTISM SPECTRUM DISORDER A THESIS Presented to the Faculty of The University of Texas Health Science Center at Houston and The University of Texas M.
    [Show full text]
  • An Sirna-Based Functional Genomics Screen for the Identification of Regulators of Ciliogenesis and Ciliopathy Genes
    This is a repository copy of An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/88332/ Version: Accepted Version Article: Wheway, G, Schmidts, M, Mans, DA et al. (75 more authors) (2015) An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes. Nature Cell Biology, 17 (8). pp. 1074-1087. ISSN 1465-7392 https://doi.org/10.1038/ncb3201 Reuse Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of the full text version. This is indicated by the licence information on the White Rose Research Online record for the item. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes Gabrielle Wheway*1, Miriam Schmidts*2,3,4,5, Dorus A. Mans*3,4, Katarzyna Szymanska*1, Thanh-Minh T. Nguyen*3,4, Hilary Racher6, Ian G. Phelps7, Grischa Toedt8, Julie Kennedy9, Kirsten A. Wunderlich10, Nasrin Sorusch10, Zakia A.
    [Show full text]
  • ABSTRACT Using a Bioinformatics Approach to Identify Genes That
    ABSTRACT Using a bioinformatics approach to identify genes that have possible candidacy of association with retinitis pigmentosa: GeneWeaver Natasha Lie Director: Erich J. Baker, Ph.D. Retinitis pigmentosa (RP) is a retinal degenerative disorder that affects about 1 in 3,000 people. The disease is genetic in cause, and currently there is no cure. The genetic cause of the disease may be contributed to one of several different genes, underscoring the complex genetic underpinnings of this disease. The information required to determine which genes are potentially causative for RP may exist, but it is difficult to determine which genes are most suitable for study because of the immense wealth and breadth of available information. In other words, large-scale heterogeneous species-specific data often obfuscates the true causative genetic background of RP. In this study we describe a method of identifying genes that may contribute to RP using the bioinformatics techniques of graph theory and database utilization. We report a potential ranked list of genes in which disruptions are likely causative of RP. APPROVED BY DIRECTOR OF HONORS THESIS: ___________________________________________________ Dr. Erich Baker, School of Engineering and Computer Science APPROVED BY THE HONORS PROGRAM: ______________________________________________ Dr. Elizabeth Corey, Director DATE: _________________________ USING A BIOINFORMATICS APPROACH TO IDENTIFY GENES THAT HAVE POSSIBLE CANDIDACY OF ASSOCIATION WITH RETINITIS PIGMENTOSA: GENEWEAVER A Thesis Submitted to the
    [Show full text]
  • Part of the SPATA7 Gene in a Consanguineous Israeli Muslim Arab Family
    Molecular Vision 2015; 21:306-315 <http://www.molvis.org/molvis/v21/306> © 2015 Molecular Vision Received 18 July 2014 | Accepted 12 March 2015 | Published 15 March 2015 Novel homozygous large deletion including the 5′ part of the SPATA7 gene in a consanguineous Israeli Muslim Arab family Anja-Kathrin Mayer,1 Muhammad Mahajnah,2,3 Ditta Zobor,4 Michael Bonin,5 Rajech Sharkia,6,7 Bernd Wissinger1 (The second, fifth and last authors contributed equally to this work) 1Molecular Genetics Laboratory, Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany; 2Child Neurology and Development Center, Hillel-Yaffe Medical Center, Hadera, Israel; 3The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel; 4Institute for Ophthalmic Research, Centre for Ophthalmology, University of Tuebingen, Tuebingen, Germany; 5Department of Medical Genetics, Institute for Human Genetics, University of Tuebingen, Tuebingen, Germany; 6The Triangle Regional Research and Development Center, Kfar Qari’, Israel; 7Beit-Berl Academic College, Beit-Berl, Israel Purpose: To identify the genetic defect in a consanguineous Israeli Muslim Arab family with juvenile retinitis pigmen- tosa (RP). Methods: DNA samples were collected from the index patient, her parents, her affected sister, and two non-affected siblings. Genome-wide linkage analysis with 250 K single nucleotide polymorphism (SNP) arrays was performed us- ing DNA from the two affected patients. Owing to consanguinity in the family, we applied homozygosity mapping to identify the disease-causing gene. The candidate gene SPATA7 was screened for mutations with PCR amplifications and direct Sanger sequencing. Results: Following high-density SNP arrays, we identified several homozygous genomic regions one of which included the SPATA7 gene.
    [Show full text]
  • Homozygosity Mapping Reveals Null Mutations in FAM161A As a Cause of Autosomal-Recessive Retinitis Pigmentosa
    REPORT Homozygosity Mapping Reveals Null Mutations in FAM161A as a Cause of Autosomal-Recessive Retinitis Pigmentosa Dikla Bandah-Rozenfeld,1 Liliana Mizrahi-Meissonnier,1 Chen Farhy,2 Alexey Obolensky,1 Itay Chowers,1 Jacob Pe’er,1 Saul Merin,3 Tamar Ben-Yosef,4 Ruth Ashery-Padan,2 Eyal Banin,1,* and Dror Sharon1,* Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinal degenerations caused by mutations in at least 45 genes. Using homozygosity mapping, we identified a ~4 Mb homozygous region on chromosome 2p15 in patients with autosomal-recessive RP (arRP). This region partially overlaps with RP28, a previously identified arRP locus. Sequence analysis of 12 candidate genes revealed three null mutations in FAM161A in 20 families. RT-PCR analysis in 21 human tissues revealed high levels of FAM161A expression in the retina and lower levels in the brain and testis. In the human retina, we identified two alternatively spliced transcripts with an intact open reading frame, the major one lacking a highly conserved exon. During mouse embryonic development, low levels of Fam161a tran- scripts were detected throughout the optic cup. After birth, Fam161a expression was elevated and confined to the photoreceptor layer. FAM161A encodes a protein of unknown function that is moderately conserved in mammals. Clinical manifestations of patients with FAM161A mutations varied but were largely within the spectrum associated with arRP. On funduscopy, pallor of the optic discs and attenuation of blood vessels were common, but bone-spicule-like pigmentation was often mild or lacking. Most patients had nonrecord- able electroretinographic responses and constriction of visual fields upon diagnosis.
    [Show full text]